Real-world study of flash glucose monitoring among adults with type 2 diabetes within the Swedish National Diabetes Register
Authors:
Open Access
- 30 January 2023
- journal article
- research article
- Published by SAGE Publications in Diabetes & Vascular Disease Research
- Vol. 20 (1)
Abstract
Background: The Swedish National Diabetes Register (NDR) initiated registration of the FreeStyle Libre® system and other continuous glucose monitoring (CGM) systems in June 2016. We investigated change in HbA1c for people with type 2 diabetes (T2DM) using FreeStyle Libre in Sweden. Methods: We included adults with T2DM, registered in the NDR after January 1, 2014, and an index date for first use of FreeStyle Libre of June 2016 or later. Methodology was a before/after comparison of HbA1c within 6 months before the index date versus HbA1c around 6 and 12 months after the index date. Results: 711 adults with T2DM using FreeStyle Libre had HbA1c measurements within the study period . Mean HbA1c was significantly reduced at 6 months (−0.50%-unit) and at 12 months (−0.52%-unit) in this group. Degree of change was negatively correlated to baseline HbA1c. Reductions in HbA1c were observed in incident users of FreeStyle Libre with T2DM who were truly naïve to CGM or had unknown prior experience of CGM, and aged 25–74 years. Conclusions: This real‐world study on the Swedish NDR shows that people with T2DM using FreeStyle Libre system for 6 and 12 months significantly reduced their HbA1c.Keywords
Funding Information
- Abbott Diabetes Care
This publication has 17 references indexed in Scilit:
- Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 DiabetesDiabetes Care, 2019
- Optimising use of rate-of-change trend arrows for insulin dosing decisions using the FreeStyle Libre flash glucose monitoring systemDiabetes & Vascular Disease Research, 2018
- Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin InjectionsAnnals of Internal Medicine, 2017
- Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND TrialJournal of Diabetes Science and Technology, 2017
- Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled TrialDiabetes Therapy, 2016
- 2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C MeasurementDiabetes Care, 2010
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- IFCC Reference System for Measurement of Hemoglobin A1c in Human Blood and the National Standardization Schemes in the United States, Japan, and Sweden: A Method-Comparison StudyClinical Chemistry, 2004
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998